Ontogenesis of anesthesia-relevant receptors;Ontogenese anästhesierelevanter rezeptoren

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 36, Issue 11, 2001, Pages 664-682

  Reimann, B ^a   Kretz, F J ^a  

^a OLGAHOSPITAL   (Germany)

Author keywords

5 NT receptors; Acetylcholinereceptors; Dopaminreceptors; GABA receptors; Myelination; New born infants; NMDA receptors; Ontogenesis; Opioidreceptors; Premature; Serotininreceptors

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR; DOPAMINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; OPIATE; OPIATE RECEPTOR; RECEPTOR; SEROTONIN RECEPTOR;

ANESTHESIA; BRAIN MATURATION; DRUG INDUCED DISEASE; HUMAN; INFANT; MYELINATION; NEUROTRANSMISSION; NEWBORN; ONTOGENY; PREMATURITY; RECEPTOR DENSITY; RESPIRATION DEPRESSION; REVIEW;

EID: 0035161632     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18051     Document Type: Review

References (139)

1. Morphine-sensitive late components of the flexion reflex in the neonatal rat
2. Attempts to gauge the relative importance of presynaptic and postsynaptic effects of morphine on the transmission of noxious messages in the dorsal horn of the rat spinal cord
3. Opioid systems and the newborn
4. Anatomical distribution of oopioid receptors in mammalians: An overview
5. Ontogenesis of opiate receptors in regions of the ovine brain
6. Pre- and postnatal development of opiate receptor subtypes in rat spinal cord
7. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: An in situ hybridization study
8. Characterization of specific sigma opiate/phencyclidine (PCP)-binding sites in the human brain
9. Postnatal development of multiple opioid receptors in the spinal cord and development of spinal morphine analgesia
10. Neuropeptide receptors in developing and adult rat spinal cord: An in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurkinins, μ-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors
11. Ontogenesis of κ-opioid receptors in rat brain using 3HU-69593 as a binding ligand
12. Biochemical characterization and regional quantification of μ, δ and κ opioid binding sites in spinal cord
13. Differential ontogeny of multiple opioid receptors
14. Autoradiographic distribution of μ, δ and κ opioid binding sites in the superficial dorsal horn, over the rostrocaudal axis of the rat spinal cord
15. The prenatal developmental profile of expression of opioid peptides and receptors in the mouse brain
16. Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain
17. Distribution of enkephalin in the human fetus and spinal cord: An immunofluorescence study
18. The prenatal growth of fine diameter afferents into the rat spinal cord - A transganglionic study
19. The development of activity evoked by fine diameter cutaneous fibres in the spinal cord fo the newborn
20. The postnatal physiological and neurochemical development of peripheral sensory C-fibres
21. Immunolocalization and quantitation of a novel terminal protein in spinal cord development
22. Depression of A- and C-fibre evoked segmental reflexes by morphine and clonidine in the in vitro spinal cord of the neonatal rat
23. The behavioural response to formalin pain in preweanling rats
24. Developmental alterations in nociceptive threshold, immunoreactive calcitonin-gene related peptide, substance P and fluoride resistant acid phosphatase in neonatally capsicain treated rats
25. The functional development of descending inhibitory pathways in the dorsolateral funiculus of the newborn rat spinal cord
26. Developmental changes in the laminar termination of A fibre cutaneous sensory afferents in the rat spinal cord dorsal horn
27. Opioid-dependant growth of glial cultures: Suppression of astrocyte DANN synthesis by metenkephalin
28. Endogenous opioids regulate dendritic growth and spine formation in developing rat brain
29. Endogenous opioid systems and the regulation of dendritic growth and spine formation
30. Morphine alters astrocyte growth in primary cultures of mouse glial cells: Evidence for a direct effect of opiates on neuronal mutation
31. Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth
32. Effects of morphine, pentobarbital and amphetamine on formalin-induced behaviours in infant rats. Sedation versus specific suppression of pain
33. Pharmacologic basis for the increased sensitivity of the newborn rat to morphine
34. A comparison of the antinociceptive effects of opioid agonists in neonatal and adult rats in phasic and tonic nociceptive tests
35. Analysis of the antinociceptive actions of the kappa-opioid agonist enadoline (Cl-977) in neonatal and adult rats: Comparison to kappa-opioid receptor mRNA ontogeny
36. Morphine- and ketocyclazocine-induced analgesia in the developing rat: Differences due to type of noxious stimulus and body topography
37. κ-opioid receptor-mediated analgesia in the developing rat
38. Hormonal-metabolic stress response in neonates undergoing cardiac surgery
39. Development of sensory information processing - The ontogenesis of opioid binding sites in nociceptive afferents and their significance in the clinical setting
40. Ontogeny of opioid pharmacology and receptors: High and low affinity site differences
41. The effects of systemic morphine on behaviour and EEG in newborn rats
42. Thermal hyperalgesia in association with the development of morphine tolerance in rats: Roles of excitatory amino acid receptors and protein kinase C
43. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
44. Biochemical studies of the structure and function of the NMDA-subtype of glutamate receptors
45. Intrathecal NMDA activates both nociceptive and antinociceptive systems
46. Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats
47. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn
48. Ontogeny of NMDA R1 subunit protein expression in five regions of rat brain
49. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
50. Characterization of NMDA receptor subunit-specific antibodies: Distribution of NR2A and NR2B receptor subunits in rat brain and ontogenic profile in the cerbellum
51. NMDA receptor heterogeneity during post-natal development of the rat brain: Differential expression of the NR2A, NR2B and NR2C subunit proteins
52. Differential expression and co-assembly of NMDAz1 and e subunits in the mouse cerebellum during postnatal development
53. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex
54. Developmental and regional expression of NMDA receptor subtypes containing the NR2D subunit in rat brain
55. Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody
56. The postnatal development of spinal sensory processing
57. 2+i elevation in substantia gelatinosa neurons of neonatal rat spinal cord
58. Regulation of N-methyl-D-aspartate (NMDA) receptor function during the rearrangement of developing neuronal connections
59. Chronic embryonic MK-801 exposure disrupts the somatotopic organization of cutaneous nerve projections in the chick spinal cord
60. GABA receptor mechanisms in the central nervous system
61. A receptor channel function in the nervous system
62. B receptors in the central nervous system
63. B receptors in the hippocampus have different pharmacological properties
64. B receptors: Drugs meets clones
65. Biochemical development of the human brain. II. Some parameters of the GABAergic System
66. Clusters of coupled neuroblasts in embryonic neocortex
67. A-receptor subtypes in developing brain. Actors of Spectators?
68. 1 subunit mRNA in the rat forebrain
69. Control of NMDA receptor-mediated activity by GABAergic mechanisms in mature and developing rat neocortex
70. Transient expression of polysynaptic NMDA receptor-mediated activity during neocortical development
71. Postnatal maturation of gamma-aminobutyric acid A- and B-mediated inhibition in the CA3 hippocampal region of the rat
72. B-mediated inhibitions in the CA3 hippocampal region of the rat
73. B inhibition in rat somatosensory cortex
74. Transient expression of a novel type of GABA response in rat CA3 hippocampal neurones during development
75. Gamma-aminobutyric acid (GABA): A fast excitatory transmitter which may regulate the development of hippocampal neurones in early postnatal life
76. Distribution of NMDA receptor binding in developing mouse spinal cord
77. 2+ transients in embryonic rat dorsal horn neurons in culture
78. Differential ontogenesis of type I and II benzodiazepine receptors in mouse cerebellum
79. Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain
80. Brain dopamine receptors: A primer on their current status, basic and clinical
81. Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment
82. 1-like receptors in rat cortical and striatolimbic brain regions: An autoradiographic study
83. 2-like receptors
84. Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens
85. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum
86. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol
87. 3 receptor mRNA in proliferative zones during embryonic development of the rat brain
88. Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor
89. Developmental differences in the analgesia produced by the central cholinergic system
90. 3Hacetylcholine in rat brain
91. Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain
92. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain
93. Ontogeny of muscarinic receptors in rat brain
94. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
95. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment
96. Postnatal changes of nicotinic acetylcholine receptor α2, α3, α4, α7 and β2 subunit genes expressionin rat brain
97. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous system
98. Differential regulation of muscle acetylcholine receptor γ and ε subunit mRNAs
99. Expression of neuronal acetylcholine receptor genes in vertebrat skeletal muscle during development
100. The changing scene of neurotrophic factors
101. Expression of functional α7 nicotinic acetylcholine receptor during mammalian muscle development and denervation
102. Acetylcholine, choline and choline acetyltransferase activity in the developing brian of normal and hypothyroid rats
103. Acetylcholine concentrations in the developing brain appear to affect emotionality and mental capacity in later life
104. High-affinity uptake of choline, a marker for cholinergic nerve terminals, is not specific in developing rat brain
105. Development of cholinergic system in control and intra-uterine growth retarded rat brain
106. Effects of ethanol on muscarinic receptor-stimulated phosphoinositide metabolism during brain development
107. Muscarinic receptors in the central nervous system of the rat. III. Postnatal development of binding of 3H-propylbenzilylcholine mustard
108. Neonatal lesions of the basal forebrain cholinergic neurons result in abnormal cortical development
109. Acetylcholine analogue stimulates DNA synthesis in brain-derived cells via specific muscarinic receptor subtypes
110. Postnatal changes in serotonin receptors following prenatal alterations in serotonin levels: Further evidence for functional fetal serotonin 1 receptors
111. A review of central 5-HT receptors and their function
112. 1B-binding sites in the rat CNS
113. 1C receptors
114. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacology and clinical effects - Role of 5-HT2 receptors
115. Allosteric modulation of 5-HT3 receptors: Focus on alcohols and anaesthetic agents
116. 7 receptor: Orphan found
117. 4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo
118. 4 receptors in the mouse passive avoidance test
119. Regional distribution and ontogeny of 5-HT4 binding sites in rat brain
120. 2 receptors during rat embryogenesis
121. Fetal human brain exhibits a prenatal peak in the density of serotonin 5 HT1A receptors
122. The ontogenic development of serotonin (5-HT1) receptors in various cortical regions of the rat brain
123. Expression of 5-HT7 receptor mRNA in rat brain during postnatal development
124. Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development
125. Regional differences in the ontogeny of 5-hydroxytryptamine-1C binding sites in rat brain and spinal cord
126. In vivo and in vitro development of serotonergic neurons
127. Serotonin regulates gap junction coupling in the developing rat somatosensory cortex
128. The role of serotonin and serotonin receptors in development of the mammalian nervous system
129. Qualitative and quantitative development of the visual cortex in man
130. The development of synapses in striate cortex of man
131. Synaptic remodelling and elimination as integral processes of synaptogenesis
132. Stadien der hirnentwicklung und ihre störungen
133. Studies of Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen
134. Pattern of myelination and distribution of neuroglial cells along the developing optic system of the rat and rabbit
135. Ontogenesis of the axolemma and axoglial relationships in myelinated fibers: Electrophysiological and freeze-fracture correlates of membrane plasticity
136. Maturation of central somatosensory conduction time in infancy and childhood